China Resources Pharmaceutical Group Ltd
CR Pharma Waste Data Preview
In 2023, CR Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into CR Pharma's Waste Treatment Practices
In 2023, CR Pharma generated a total of 160,060 metric tonnes of waste.
Of this amount, 89.74% of CR Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 10.26% was disposed of through landfilling, incineration, or combustion.
CR Pharma's Waste Recovery Rate
How much of CR Pharma's waste is recycled or recovered?
In 2023, CR Pharma reported a total waste generation of 160,060 metric tonnes, of which 89.74% was recovered through recycling, reuse, or composting. This high recovery rate suggests that CR Pharma has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Has CR Pharma reduced its environmental waste footprint over time?
Since 2021, CR Pharma's total waste generation increased by 88.86%, including a 223.98% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
CR Pharma’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into CR Pharma’s Generation of Hazardous and Non-Hazardous Waste
In 2023, CR Pharma generated a total of 160,060 metric tonnes of waste.
Of this amount, 3.19% of CR Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 96.81% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
CR Pharma’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How CR Pharma reduced the environmental impact of its waste?
Since 2021, CR Pharma's total waste generation increased by 88.86%, including a 223.98% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, CR Pharma maintained relatively stable levels of hazardous waste in the long run, but saw a 74.42% drop in 2023, potentially signaling the beginning of a positive downward trend.
Overall, CR Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.